SANDRINE ASPESLAGH

Invariant natural killer T cells in rheumatic disease : a joint dilemma

Michael Drennan (UGent) , SANDRINE ASPESLAGH (UGent) and Dirk Elewaut (UGent)

(2010) NATURE REVIEWS RHEUMATOLOGY. 6(2). p.90-98

Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid

SANDRINE ASPESLAGH (UGent) , Yali Li, Tine Decruy (UGent) , Katrien Van Beneden (UGent) , Koen Venken (UGent) , Matthias Trappeniers (UGent) , Serge Van Calenbergh (UGent) , Dirk Zajonc and Dirk Elewaut (UGent)

(2010) CLINICAL IMMUNOLOGY. 135(suppl.). p.S40-S40

Add to list

Journal Article
A1
open access

Synthesis and evaluation of amino-modified α-GalCer analogues

Matthias Trappeniers (UGent) , René Chofor (UGent) , SANDRINE ASPESLAGH (UGent) , Yali Li, Bruno Linclau (UGent) , Dirk M Zajonc, Dirk Elewaut (UGent) and Serge Van Calenbergh (UGent)

(2010) ORGANIC LETTERS. 12(13). p.2928-2931

Add to list

Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid

SANDRINE ASPESLAGH (UGent) , Yali Li, Tine Decruy (UGent) , Katrien Van Beneden (UGent) , Michael Drennan (UGent) , Koen Venken (UGent) , Matthias Trappeniers (UGent) , Serge Van Calenbergh (UGent) , Dirk Zajonc and Dirk Elewaut (UGent)

(2010) CLINICAL IMMUNOLOGY. 135(suppl.). p.S13-S14

Add to list

Suppression of human natural killer T cell function by CD4(+)CD25(+)FOXP3(+) regulatory T cells

Koen Venken (UGent) , Tine Decruy (UGent) , Kim Deswarte (UGent) , SANDRINE ASPESLAGH (UGent) , Serge Van Calenbergh (UGent) , Bart Lambrecht (UGent) and Dirk Elewaut (UGent)

(2010) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 28(4). p.614-614

Add to list

Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells

Katleen Braet (UGent) , SANDRINE ASPESLAGH (UGent) , W VANDAMME, K WILLECKE, PEM MARTIN, WH EVANS and Luc Leybaert (UGent)

(2003) JOURNAL OF CELLULAR PHYSIOLOGY. 197(2). p.205-213

Academic Bibliography

SANDRINE ASPESLAGH

Invariant natural killer T cells in rheumatic disease : a joint dilemma

Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid

Synthesis and evaluation of amino-modified α-GalCer analogues

Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid

Suppression of human natural killer T cell function by CD4(+)CD25(+)FOXP3(+) regulatory T cells

Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells

Contents

Support

Contact